Calls
1
u/Fuzzy-Eye-7976
Reddit r/pennystocks
Win Rate
100.0%
return
+15.3%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 27
$3.46
+15.3%
The author argues RZLT is massively undervalued after a ~90% panic sell, because sunRIZE's failed endpoints were caused by a large placebo effect while the drug hit target drug levels and biomarkers moved as expected. The causal mechanism is that the open-label extension, with all 59 patients continuing and some on drug for 18 months, plus EAP tumour HI data showing 75% stopped IV glucose/TPN, signal real efficacy and support the single-arm Phase 3 upLIFT study. The stated bear risk is the primary and key secondary endpoint miss, which the author attributes to trial design rather than drug failure. The author frames this as a 2-5x growth opportunity, with upLIFT as the key ongoing catalyst.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Fuzzy-Eye-7976 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: RZLT.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
